ClinicalTrials.gg
CompletedNCT05752305Updated Dec 6, 2023

Use of Corticosteroids in Third Molar Surgery

A Phase 2/3 interventional study of Dexamethasone 4 Mg/mL Injectable Solution and MethylPREDNISolone 40 Mg/mL Injectable Suspension in Inflammation, Pain, Postoperative and Trismus, sponsored by Universidad de Granada. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-06.

Primary conditionPain, PostoperativeRegistry: InflammationReclassifiedWhy we changed it
Registry
Inflammation — the first condition term the registry derived for this study.
ClinicalTrials.gg
Pain, Postoperative
Why
  1. Inflammation is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Pain, Postoperative.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Universidad de Granada · Phase 2/3, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jan 2022, registered Feb 2023).
Phase
Phase 2/3
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Surgical extraction of retained lower third molars is associated with the development of postoperative complications, including inflammation, trismus and postoperative pain, that lead to a decrease in patients' quality of life. Therefore, the use of drugs is essential to reduce the morbidity associated with surgery, with NSAIDs and corticosteroids being the most commonly used drugs.

Read the detailed description

Surgical extraction of retained lower third molars is associated with the development of postoperative complications, including inflammation, trismus and postoperative pain. Traditionally, NSAIDs have been used for the treatment of postoperative pain and inflammation, although corticosteroids are increasingly used in oral surgery, as they have proven to be clinically effective in reducing postoperative complications without causing serious adverse effects. Although numerous studies have been carried out comparing different corticosteroids in order to determine which of them is the most effective, there is still no clinical protocol regulating the use of these drugs in oral surgery. Therefore, this clinical trial is based on comparing two of the most studied corticosteroids used in oral surgery to date: dexamethasone and methylprednisolone.

This study is based on the preoperative administration of 8mg of dexamethasone or 40mg of methylprednisolone via submucosa, randomly, in patients undergoing surgical extraction of a retained lower third molar, to determine which of these two drugs is more effective in the prevention of inflammation, trismus and postoperative pain.

02

Conditions studied

  • Inflammation
  • Pain, Postoperative
  • Trismus

Browse trials for

03

In context

Pain, Postoperative Reclassified

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's enrollment of 84 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Universidad de Granada is the lead sponsor of 246 studies on the registry; 43 are open to participants now.

Compared within Pain, Postoperative, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Inflammation. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over 18 years of age
  • Indication for surgical extraction of a retained lower third molar

Exclusion criteria

Exclusion Criteria:

  • Patients treated with in the last 3 months
  • Patients treated with NSAIDs in the last 7 days
  • Patients with to the drug
  • Patients with a medical condition that contraindicates the administration of the drug
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Methylprednisolone group

    Preoperative administration of 40mg of methylprednisolone via submucosa

    Drug: MethylPREDNISolone 40 Mg/mL Injectable Suspension

  • Experimental
    Dexamethasone group

    Preoperative administration of 8mg of dexamethasone via submucosa

    Drug: Dexamethasone 4 Mg/mL Injectable Solution

Interventions

  • DrugDexamethasone 4 Mg/mL Injectable Solution

    Drug page: Dexamethasone

    Preoperative submucosal administration of 8mg of dexamethasone or 40mg of methylprednisolone.

  • DrugMethylPREDNISolone 40 Mg/mL Injectable Suspension

    Drug page: Methylprednisolone

    Preoperative submucosal administration of 8mg of dexamethasone or 40mg of methylprednisolone.

06

What researchers measure

Primary outcomes

  1. Postoperative inflammation following third molar surgical extraction

    Postoperative swelling was determined by measuring tragus-chin distance, tragus-labial cleft distance and eye angle-jaw angle distance, using a millimeter ruler.

    Time frame: 7 days

  2. Postoperative trismus following third molar surgical extraction

    Postoperative trismus was assessed by measuring the patient's maximum mouth opening (measuring the distance between the incisal edge of the upper central incisor and the lower central incisor) using a millimeter ruler.

    Time frame: 7 days

  3. Postoperative pain following third molar surgical extraction

    Postoperative pain was measured using the Visual Analogue Scale (VAS): patients were asked to assign a numerical value from 0-100 (0 being no pain and 100 the maximum pain).

    Time frame: 7 days

07

Study locations

1 site
  • Unai Fernández Martín
    Granada, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05752305
Responsible party
Unai Fernández Martín (Principal Investigator, Universidad de Granada) — Principal investigator
First posted
Mar 2, 2023
Start date
Jan 15, 2022
Primary completion
Jul 1, 2023
Completion
Jul 15, 2023
Last update
Dec 6, 2023

Study contacts

Unai Fernández
principal investigator · Universidad de Granada

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Dexamethasone · Methylprednisolone

Start the discussion